LCLu Cheng

Lu Cheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lu Cheng has a total of 39 co-authors. Here are the top co-authors by number of shared publications:

  • Biwen Wang

    Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China

    2 shared publications
  • Han Li

    Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China

    2 shared publications
  • Huaicai Zeng

    Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin, China

    2 shared publications
  • Jiemei Li

    Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China

    2 shared publications
  • Juanhua Li

    Department of Public Health, Shenzhen Nanshan Center for Chronic Disease Control, Shenzhen, China

    2 shared publications
  • Ning Qin

    Department of Sanitary Chemistry, School of Public Health, Guangxi Medical University, Nanning, China

    2 shared publications

Latest Publications

  • Mediation effects of thyroid hormones in the associations between essential metal elements and anxiety or depression symptoms in the elderly

    by Juanhua Li, Wenqi Wang, Yang Peng, Ning Qin, Jiemei Li, Ying Wei, Biwen Wang, Huaicai Zeng, Han Li, Lu Cheng

  • Open Access

    Trend and burden of Alzheimer's disease and other dementias in China 1990–2021: a systematic analysis with forecasts to 2035

    by Kangqian Lin, Jie Yang, Huimin Li, Siting Zhong, Xiaoxue Zeng, Wenzhuo Hu, Lu Cheng, Shan Xu

    Background: Alzheimer's Disease (AD) has become a major public health problem affecting the health of the elderly as the global population ages. This study aims to analyze the epidemiological characteristics of AD in China, predict its future trends, and explore coping strategies, with the aim of providing a scientific basis for public health policy making. Methods: Using data from the Global Burden of Disease Study 2021, this study assessed the underlying prevalence characteristics and trends in AD age-standardized incidence and mortality using a combination of joint point regression models and (Bayesian) age-period-cohort models. Results: The age-standardized incidence and mortality of AD and other dementias in China in 2021 were 151.47 /100 000 and 30.82/10 000, and the age-standardized rate of disability-adjusted life year was 562.39 /100 000. Between 1990 and 2021, the age-standardized incidence showed an increasing trend, while the age-standardized mortality declined slightly. Age is a significant risk factor for incidence and mortality in AD and other dementias, with both incidence and mortality increasing significantly with age. Period and cohort effects showed fluctuations in incidence and mortality across time and cohorts. Projection analyses suggest that the standardized incidence and mortality for AD and other dementias will increase steadily between 2022 and 2035. Conclusion: The age-standardized incidence and mortality for AD and other dementias increase significantly with age and are higher for female than for male. Despite a slight decline in mortality in recent years, the age-standardized incidence is still rising and is projected to continue to increase over the next 10 years. Suggesting that the burden of the disease on the public health system may further increase, there is an urgent need to strengthen early screening, diagnosis and interventions to cope with the growing disease burden in the future.

  • Open Access

    Multi-metal mixture exposure and cognitive function in urban older adults: The mediation effects of thyroid hormones

    by Zhuoqi Zhu, Juanhua Li, Yang Peng, Ning Qin, Jiemei Li, Ying Wei, Biwen Wang, Yunfei Liao, Huaicai Zeng, Lu Cheng, et al.


  • Open Access

    Critical Windows of Prenatal Exposure to Cadmium and Size at Birth

    by Lu Cheng, Bin Zhang, Tongzhang Zheng, Jie Hu, Aifen Zhou, Bryan A. Bassig, Wei Xia, David A. Savitz, Stephen Buka, Chao Xiong, et al.

    Prenatal cadmium (Cd) exposure has been associated with adverse birth outcomes, but the findings of previous studies are inconsistent. We measured Cd concentrations in urine samples at or near 13, 24, and 35 gestational weeks from 282 women in Wuhan, China. We used generalized estimating equation models to assess the associations between maternal creatinine adjusted urinary Cd concentrations at each trimester and birth size. A significant inverse association was observed between higher maternal Cd levels measured during the 1st trimester and birth size in girls. For each log unit increase in Cd (µg/g creatinine) levels from the 1st trimester, there was a decrease in birth weight by 116.99 g (95% confidence interval (CI): −208.87, −25.11 g). The Cd levels from the 1st and 2nd trimesters were also borderline significantly associated with ponderal index in girls. Joint estimation of trimester-specific effects suggested that associations with Cd levels for ponderal index (pint = 0.02) were significantly different across trimesters, and differences for effects across trimesters for birth weight were marginally significant (pint = 0.08) in girls. No significant associations were observed between Cd levels from any trimester and birth size in boys. Maternal Cd exposure during earlier periods of pregnancy may have a larger impact on delayed fetal growth.